Apothecary Shoppe Recalls Phentolamine Vials Due to Sterility Concerns
The Apothecary Shoppe LLC is recalling SIU-Phentolamine 5 mg/mL vials in Oklahoma due to lack of documentation for environmental monitoring during production.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to a documentation error regarding environmental monitoring. As no illnesses or injuries are reported and the hazard is a theoretical risk of contamination rather than a confirmed high-risk pathogen or structural defect, it falls under the 'Moderate' criteria for low-risk contamination or voluntary precautionary recalls.
Plain-English summary
The Apothecary Shoppe LLC, a compounding pharmacy in Tulsa, Oklahoma, is recalling SIU-Phentolamine 5 mg/mL in Normal Saline, 10 mL vials. The recall is limited to Lot # 03102015@42 with a beyond-use date of 09/06/2015. The product was distributed in Oklahoma.
The recall was initiated due to a lack of assurance of sterility. Specifically, there was a lack of documentation confirming proper environmental monitoring during the time the medication was produced. This documentation gap raises concerns about the sterility of the compounded medication.
Consumers and healthcare providers who have this specific lot of SIU-Phentolamine should stop using it and contact The Apothecary Shoppe LLC or their healthcare provider for instructions on disposal or replacement. The FDA classifies this as a Class II recall, indicating a reasonable probability that use of the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- SIU-Phentolamine 5 mg/mL in Normal Saline, Rx Only, 10 mL Vial, Apothecary Shoppe, Compounding Pharmacy, Tulsa OK 74135
- Manufacturer
- The Apothecary Shoppe LLC
- Category
- Drug — Compounded Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 03102015@42
- BUD 09/06/2015
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 28 recalled by The Apothecary Shoppe LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 28 products in this recall →Related recalls
Same manufacturer · The Apothecary Shoppe LLC
See all →- SevereThe Apothecary Shoppe Recalls Tri-Mix 18/1/10 Due to Sterility Concerns
FDA (Drugs) · 2016-10-12
- SevereApothecary Shoppe Recalls Phenotolamine and Prostaglandin Vials Due to Sterility Concerns
FDA (Drugs) · 2016-10-12
- SevereMethylcobalamin Injection Recalled Due to Sterility Assurance Issues
FDA (Drugs) · 2016-10-12
- ModerateApothecary Shoppe Recalls SIU-Tri-Mix Injection Due to Sterility Concerns
FDA (Drugs) · 2015-08-12
- ModerateApothecary Shoppe Recalls Papaverine and Phentolamine Injection Due to Sterility Concerns
FDA (Drugs) · 2015-08-12
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereApothecary Shoppe Recalls Phenotolamine and Prostaglandin Vials Due to Sterility Concerns
FDA (Drugs) · 2016-10-12
- SevereThe Apothecary Shoppe Recalls Tri-Mix 18/1/10 Due to Sterility Concerns
FDA (Drugs) · 2016-10-12
- SevereMethylcobalamin Injection Recalled Due to Sterility Assurance Issues
FDA (Drugs) · 2016-10-12
- SevereFDA Recalls Papaverine-Phentolamine Injectable Due to Insanitary Compounding Conditions
FDA (Drugs) · 2019-04-17
- HighPhentolamine Injectable Drug Recalled Due to Sterility Concerns
FDA (Drugs) · 2022-11-09
- SevereApothecary Shoppe Recalls Estradiol and Progesterone Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-10-09